Epigenetic modulation therapy (unspecified agent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epigenetic modulation therapy (unspecified agent), covering 2016-06-07 to 2016-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 2]